What are peptides?

A peptide is a short chain of amino acids. Amino acids are the building blocks your body uses to make proteins, and a peptide is a small run of them joined together, usually somewhere between 2 and 50.

That is the whole definition. Everything else is detail about which chain, and what it does.

Peptide, protein, amino acid

These three words describe the same chemistry at three lengths.

• An amino acid is a single unit.
• A peptide is a short chain of them, roughly 2 to 50 units.
• A protein is a long chain, typically 50 units or more, folded into a specific shape.

The boundary at 50 is a convention rather than a law of nature, and you will see sources draw it in slightly different places. Nothing important turns on it. The useful point is that length changes behaviour: short chains are easier for the body to absorb and break down, and easier to manufacture, which is part of why they have become so widely discussed.

Your body already makes thousands of them

Peptides are not a novel class of substance. They are one of the ordinary ways the body sends signals. Insulin is a peptide. So are many of the hormones that regulate appetite, growth, inflammation and sleep. When a peptide reaches a receptor, it acts as a message: do more of this, less of that.

That signalling role is exactly what makes synthetic peptides interesting to researchers. If a natural peptide tells the body to repair tissue or suppress appetite, a manufactured one that binds the same receptor might do the same thing on purpose.

Why they are suddenly everywhere

Three things happened at once. Peptide drugs started working. Several went through full clinical trials, were approved by regulators and turned out to be genuinely effective, particularly in metabolic medicine. That success was real and it was large.

Manufacturing got cheap. Synthesising a short chain is far simpler than producing a folded protein, so compounds that were once laboratory curiosities became easy to make in quantity.

And the conversation outran the evidence. The approved successes gave the whole category credibility, and that credibility now attaches to compounds that have never been tested in a human being. This is the single most important thing to understand about peptides: they are not one thing with one safety profile.They are a chemical format, and the range inside it is enormous.

How much is actually known

Of the 110 peptides catalogued in this reference, 32 have human efficacy evidence we rate at 4 or 5 stars, and 28 sit at the bottom band of the five point scale, meaning human efficacy evidence is absent or minimal. Separately, the safety profile is largely unknown for 27of them.

Evidence and safety are tracked as two different figures here, because they are two different questions. A compound can be well studied and still carry real risk, and a compound with a quiet safety record may simply never have been studied closely enough for problems to show up. Collapsing them into a single score is how a reference misleads without ever stating a falsehood.

What this means if you are looking something up

Ask three questions about any individual peptide, in this order.

1. Is there human evidence, and how much? Animal and test-tube results are a reason to run a trial, not a reason to draw a conclusion.
2. Is the safety profile characterised? Absence of reported harm is not the same as evidence of safety.
3. What is its regulatory status where you live, and as at when? This moves. A status without a date attached is unreliable by default.

Those three questions are what this reference is built to answer, compound by compound, with a citation behind every clinical and regulatory claim.

Educational reference, not medical advice, and not a recommendation to use any compound. Decisions about any specific peptide belong with a qualified clinician. Edition 1.0, regulatory information current as at 16 September 2026.